Biased Agonism as a Novel Strategy to Harness the Proresolving Properties of Melanocortin Receptors Without Eliciting Melanogenic Effects

Journal of Immunology - United States
doi 10.4049/jimmunol.1402645
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Melanocortin Receptors as Novel Effectors of Macrophage Responses in Inflammation

Frontiers in Immunology
AllergyImmunology
2011English

A Pharmacological Primer of Biased Agonism

Endocrine, Metabolic and Immune Disorders - Drug Targets
EndocrinologyAllergyImmunologyMetabolismDiabetes
2011English

Exploring Biased Agonism at FPR1 as a Means to Encode Danger Sensing

Cells
2020English

Stepwise Autophosphorylation Regulates Biased Agonism of the Insulin Receptor

2019English

Targeting of the Adenosine Receptors as a Novel Strategy for the Treatment of Arterial Hypertension

Journal of Neurology & Neurophysiology
2014English

Biased Agonism in Drug Discovery - Is It Too Soon to Choose a Path?

Molecular Pharmacology
Molecular MedicinePharmacology
2018English

2-(3, 4-Dihydroxybenzylidene)malononitrile as a Novel Anti-Melanogenic Compound

Oncotarget
Oncology
2017English

Biased Agonism: An Emerging Paradigm in GPCR Drug Discovery

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2016English

A Complementary Scale of Biased Agonism for Agonists With Differing Maximal Responses

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy